GnRH analogue for the prevention of ovarian hyperstimulation syndrome: a pilot study
Received 16 December 2006; received in revised form 9 April 2008; accepted 9 April 2008. published online 11 August 2008.
Continuation of GnRH analogue after ovum retrieval produces a faster decline in vascular endothelial growth factor levels and ascitis in women at risk of ovarian hyperstimulation syndrome
aIVI Madrid, Calle Santiago de Compostela 88, Madrid, Spain
bIVI Valencia, Plaza Policia Local 3, Valencia, Spain
Reprint requests: Juan Giles, M.D., IVI Madrid, Unidad de Reproducción, C/Santiago de Compostela 88, Madrid 28035, Spain (FAX: 34-913867133).
J.G. has nothing to disclose. A.R. has nothing to disclose. J.A.G-V. has nothing to disclose. A. Pacheco has nothing to disclose. J.P. has nothing to disclose. A. Pellicer has nothing to disclose.
ABSTRACT